Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial.

ABSTRACT:

SUBMITTER: Keitel V 

PROVIDER: S-EPMC8127198 | biostudies-literature | 2021 May

REPOSITORIES: biostudies-literature